A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer

por Hoff, P M, Kopetz, S, Thomas, M B, Langleben, A, Rinaldi, D, Anthony, L, Wolff, R A, Lassere, Y, Abbruzzese, J L
Publicado 2008

Double antibody radioimmunoassay for monitoring metastatic breast cancer.

por Schecter, R. L., Major, P. P., Kovac, P. E., Ishida, M., Kovalik, E. C., Dion, A. S., Langleben, A., Boileau, G., Boos, G., Panasci, L.
Publicado 1988